Fiona Elizabeth Scott

6PUBLICATIONS
55CO-AUTHORS
Haematological tumoursMolecular targetsBiomolecular modelling and designCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 03, 2026
Novel antibody-drug conjugates targeting EphA3 in tumours and the tumour microenvironment.

|Oct 27, 2026
An Exploratory Study of ABT-806, a Tumor-Specific Anti-EGFR Antibody, in Subjects with Recurrent or Metastatic Head and Neck and Other Squamous Cell Carcinomas.

|Jun 10, 2026
A Phase I and Biodistribution Study of Ifabotuzumab, a Humanized Agonistic EphA3-Targeted Antibody, in Patients with Recurrent Glioblastoma.

|Sep 27, 2025
Characterisation of mAb104 Antibody-Drug Conjugates Targeting a Tumour-Selective HER2 Epitope.

Sagun Parakh, Nhi Huynh, Laura D Osellame

|Jun 20, 2025
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial.

Eliza A Hawkes, Jodie B Palmer, Richard Khor

|May 13, 2025
Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.

Sagun Parakh, Nhi Huynh, Diana Dong Cao

Pageof 1

Frequent Collaborators

3 joint publications

Sagun Parakh

3 joint publications

Andrew M Scott

3 joint publications

Peter W Janes

2 joint publications

Stacey Allen